GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » Price-to-Free-Cash-Flow

Samsung BioLogics Co (XKRX:207940) Price-to-Free-Cash-Flow : 531.92 (As of May. 31, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co Price-to-Free-Cash-Flow?

As of today (2025-05-31), Samsung BioLogics Co's share price is ₩1032000.00. Samsung BioLogics Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩1,940.14. Hence, Samsung BioLogics Co's Price-to-Free-Cash-Flow Ratio for today is 531.92.

The historical rank and industry rank for Samsung BioLogics Co's Price-to-Free-Cash-Flow or its related term are showing as below:

XKRX:207940' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 57.57   Med: 305.15   Max: 1788.34
Current: 531.92

During the past 11 years, Samsung BioLogics Co's highest Price-to-Free-Cash-Flow Ratio was 1788.34. The lowest was 57.57. And the median was 305.15.

XKRX:207940's Price-to-Free-Cash-Flow is ranked worse than
96.52% of 230 companies
in the Biotechnology industry
Industry Median: 30.465 vs XKRX:207940: 531.92

Samsung BioLogics Co's Free Cash Flow per Share for the three months ended in Mar. 2025 was ₩468.89. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ₩1,940.14.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Samsung BioLogics Co was -84.60% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 99.30% per year.

During the past 11 years, Samsung BioLogics Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 114.30% per year. The lowest was 14.00% per year. And the median was 40.45% per year.


Samsung BioLogics Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Samsung BioLogics Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co Price-to-Free-Cash-Flow Chart

Samsung BioLogics Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,021.09 1,786.34 - 96.43 239.74

Samsung BioLogics Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.81 53.86 69.64 239.74 522.64

Competitive Comparison of Samsung BioLogics Co's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Samsung BioLogics Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Samsung BioLogics Co's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Samsung BioLogics Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Samsung BioLogics Co's Price-to-Free-Cash-Flow falls into.


;
;

Samsung BioLogics Co Price-to-Free-Cash-Flow Calculation

Samsung BioLogics Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1032000.00/1940.135
=531.92

Samsung BioLogics Co's Share Price of today is ₩1032000.00.
Samsung BioLogics Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩1,940.14.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Samsung BioLogics Co  (XKRX:207940) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Samsung BioLogics Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Samsung BioLogics Co Business Description

Traded in Other Exchanges
N/A
Address
125, Cheomdan-daero, Yeonsu-gu, Incheon, KOR
Founded in 2011, Samsung Biologics is a South Korean contract development and manufacturing organization with a global client base. Europe and the US contribute 90% of its total revenue. It provides end-to-end development and manufacturing services from cell line developments to final commercial manufacturing. As of 2023, Samsung Biologics had a total production capacity of 604,000 liters, one of the largest in the world. Its CDMO services account for 72.4% of its total revenue. The balance comes from subsidiary Samsung Bioepis, acquired in 2022. Samsung Bioepis is involved in developing and manufacturing biosimilars.

Samsung BioLogics Co Headlines

No Headlines